FHIRsmith: FHIR Resources

FHIR IG analytics

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | kr | nl | no | nz | pl | pt | se | stt | tw | uk | us | uv
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - All Kinds, Realm US

21,238 resources

Type: Text:

By Version

R2: 0
R2B: 0
R3: 568
R4: 19,738
R4B: 121
R5: 810
R6: 1

By Authority

none: 2,000
hl7: 19,236
national: 2

Start Prev Rows 8600 - 8800 Next

Package	Version	Identity	Name/Title	Status	Date	Auth
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.121.json	T Stage T3c	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.122.json	T Stage T3b	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.123.json	T Stage T3a	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.124.json	Pathological T Stage T3	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.125.json	T Stage T2c	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.126.json	T Stage T2b	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.127.json	T Stage T2a	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.128.json	Pathological T Stage T2	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.129.json	Pathological T Stage T1c	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.132.json	Pathological T Stage T1b	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.135.json	Pathological T Stage T1a	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.136.json	Pathological T Stage T1	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.137.json	Pathological T Stage T1mic	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.139.json	Pathological T Stage T0	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.142.json	Cancer Stage III	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.143.json	Cancer Stage IIIA	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.144.json	Cancer Stage IIIB	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.145.json	Cancer Stage IIIC	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.146.json	Cancer Stage IV	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.147.json	Cancer Stage IVA	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.148.json	Cancer Stage IVB	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.149.json	Cancer Stage IVC	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.151.json	Cisplatin Injectable	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.153.json	Vinorelbine Injectable	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.154.json	Gemcitabine Injectable	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.155.json	Docetaxel	active	2024-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.156.json	Pemetrexed Injectable	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.158.json	Vinblastine Injectable	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.160.json	ECOG Performance Status	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.161.json	ECOG Performance Status	active	2020-10	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.162.json	ECOG Performance Status	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.164.json	Karnofsky Performance Status	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.165.json	Carboplatin Injectable	active	2020-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.166.json	Paclitaxel	active	2024-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.168.json	Doxorubicin Injectable	active	2022-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.169.json	Irinotecan Injectable	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.179.json	Bevacizumab Injectable	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.181.json	Methotrexate	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.184.json	Breast Cancer	active	2022-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.185.json	Breast Cancer	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.191.json	Cancer Stage II	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.192.json	Cancer Stage IIA	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.193.json	Cancer Stage IIB	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.194.json	Pertuzumab Injectable	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.196.json	Ixabepilone Injectable	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.197.json	Goserelin	active	2024-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.200.json	Epirubicin Injectable	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.202.json	Ramucirumab Injectable	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.204.json	Letrozole	active	2024-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.206.json	Exemestane	active	2024-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.209.json	Fluorouracil	active	2024-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.210.json	Capecitabine Oral	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.222.json	Aprepitant Oral	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.223.json	Fosaprepitant Injectable	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.255.json	Colorectal Cancer	active	2021-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.256.json	Colorectal Cancer	active	2021-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.257.json	Colorectal Cancer Chemotherapy	active	2023-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.280.json	Cancer Stage IA	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.281.json	Cancer Stage IB	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.286.json	Cancer Stage IIC	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.291.json	Positive Result	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.292.json	Negative Result	active	2015-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.300.json	Pathological N Stage N1C	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.332.json	Daunorubicin Injectable	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.336.json	Palonosetron Injectable	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.341.json	External Beam Radiotherapy	active	2024-04	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.349.json	Metastatic Cancer	active	2023-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.439.json	T Category	active	2018-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.440.json	N Category	active	2018-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.441.json	M Category	active	2018-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.442.json	TNM Stage Group	active	2018-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.449.json	Opioids	active	2024-03	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.492.json	Pharmacological interventions for depression	active	2024-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.535.json	Ovarian Cancer	active	2023-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.536.json	Ovarian Cancer	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.537.json	Fallopian Tube Cancer	active	2022-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.539.json	Fallopian Tube Cancer	active	2022-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.541.json	Peritoneal Cancer	active	2022-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.542.json	Peritoneal Cancer	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.547.json	Cancer Stage 1C	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.555.json	Gender Female	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.556.json	Gender Male	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.557.json	Pathological N Stage N3a	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.558.json	Pathological N Stage N3b	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.560.json	Rolapitant Oral	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.599.json	Obinutuzumab Injectable	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.600.json	Ofatumumab Injectable	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.602.json	Neurokinin 1 Receptor Antagonist	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.604.json	Serotonin Receptor Antagonist	active	2025-04	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.61.json	Cetuximab Injectable	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.63.json	Panitumumab Injectable	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.81.json	Palonosetron Oral	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.88.json	Lung Cancer	active	2015-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.89.json	Lung Cancer	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.95.json	M Stage M0	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.97.json	Pathological M Stage M1	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.98.json	Pathological M Stage M1a	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.99.json	Pathological M Stage M1b	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1125.7.json	PROMIS Depression Assessment	active	2023-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1130.11.json	Sleep Apnea	active	2018-05	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1130.13.json	Septic Shock due to C. Diff	active	2019-04	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1130.15.json	Body Temperature	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1130.16.json	Diarrhea Potentially due to CDI	active	2019-04	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1130.17.json	Abdominal Distension	active	2019-04	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1130.18.json	Vomiting potentially due to CDI	active	2019-04	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1130.19.json	Ileus due to infection	active	2019-04	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1130.20.json	Clostridium difficile infection	active	2019-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1130.3.json	Radiation Therapy Indicators from CPT	active	2017-03	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1130.4.json	Diagnostic Radiology Surrounding Face and Sinus	active	2017-03	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1130.5.json	Ear Surgery Affecting the Tympanic Membrane	active	2017-03	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1130.6.json	Allergic Rhinitis Immunotherapy	active	2017-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1130.8.json	Radiology to Head and Sinus	active	2017-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1130.9.json	Immunotherapy For Allergic Rhinitis	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1136.63.json	Aortic Dissection or Ruptured Aortic Aneurysm	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.1.json	C2S Alcohol Use Disorders	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.11.json	C2S Amphetamine Use Disorders	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.12.json	C2S Cannabis Use Disorders	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.13.json	C2S Cannabis Use Disorders	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.14.json	C2S Cannabis Use Disorders	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.15.json	C2S Cannabis Use DIsorders	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.16.json	C2S Cocaine Use Disorder	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.17.json	C2S Cocaine Use Disorder	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.18.json	C2S Cocaine Use Disorder	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.19.json	C2S Hallucinogens	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.2.json	C2S Alcohol Use Disorders	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.20.json	C2S Hallucinogens	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.21.json	C2S Hallucinogens	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.22.json	C2S Hallucinogens	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.23.json	C2S HIV/AIDS Information Sensitivity	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.24.json	C2S HIV/AIDS Information Sensitivity	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.25.json	C2S HIV/AIDS Information Sensitivity	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.26.json	C2S HIV/AIDS Information Sensitivity	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.27.json	C2S HIV/AIDS Information Sensitivity	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.28.json	C2S Inhalants	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.29.json	C2S Inhalants	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.3.json	C2S Alcohol Use Disorders	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.30.json	C2S Inhalants	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.32.json	C2S Mental Health Disorders	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.33.json	C2S Mental Health Disorders	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.34.json	C2S Mental Health Disorders	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.35.json	C2S Mental Health Disorders	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.36.json	C2S Mental Health Disorders	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.38.json	C2S Opioids	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.39.json	C2S Opioids	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.4.json	C2S Alcohol Use Disorders	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.40.json	C2S Opioids	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.42.json	C2S Opioids	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.43.json	C2S Other Psychoactive Substance Use Disorder	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.44.json	C2S Other Psychoactive Substance Use Disorder	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.45.json	C2S Other Psychoactive Substance Use Disorder	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.46.json	C2S Sedative Hypnotic, or anxiolytic related disorders	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.47.json	C2S Sedative Hypnotic, or anxiolytic related disorders	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.48.json	C2S Sedative Hypnotic, or anxiolytic related disorders	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.49.json	C2S Sexuality and reproductive health information sensitivity	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.5.json	C2S Alcohol Use Disorders	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.51.json	C2S Tobacco Use Disorders	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.52.json	C2S Tobacco Use Disorders	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.53.json	C2S Tobacco Use Disorders	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.54.json	C2S Tobacco Use Disorders	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.55.json	C2S Substance Use Information Sensitivity	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.56.json	C2S Substance Use Information Sensitivity	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.58.json	C2S Sensitive Categories	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.59.json	C2S Opioids	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.6.json	C2S Amphetamine Use Disorders	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.60.json	C2S HIV/AIDS information Sensitivity	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.65.json	Test C2S Alcohol Use Disorders	active	2019-02	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.67.json	Test C2S HIV/AIDS Information Sensitivity	active	2019-02	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.7.json	C2S Amphetamine Use Disorders	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.8.json	C2S Amphetamine Use Disorders	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1142.9.json	C2S Amphetamine Use Disorders	active	2016-09	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.10.json	Diphtheria (Tests for Corynebacterium diphtheriae by Culture and Identification Method)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.1002.json	Tuberculosis (Tests for Mycobacterium species by Culture and Identification Method)	active	2023-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.1012.json	S. Typhi Infection (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.1016.json	S. Paratyphi Infection (Disorders) (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.1017.json	S. Typhi Infection (Tests for S. Typhi by Culture and Identification Method)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.1021.json	Dark Urine (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.1022.json	Acute Onset [Qualifier Value] (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.1024.json	Acute Viral Hepatitis (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.1027.json	Sepsis [Septicemia] [Bacterial] [Unspecified Organism] (ICD10CM)	active	2023-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.1029.json	Listeriosis [Listeria species] (Organism or Substance in Lab Results)	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.1030.json	Meningitis [Unspecified Cause] (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.1032.json	Encephalitis [Unspecified Cause] (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.1033.json	Encephalitis [Unspecified Cause] (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.1035.json	Indeterminate or Equivocal Lab Result Value	active	2023-01	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.1037.json	Smoking Status [Current Nonsmoker] (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.1040.json	Organisms (Tests by Unspecified Method)	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.1041.json	Organisms (Tests by Culture and Identification)	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.1044.json	Candida auris Infection (Tests for Candida auris by Culture and Identification Method)	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.1045.json	Candida auris Infection (Tests for Candida auris Nucleic Acid)	active	2023-01	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.1047.json	Parkinson’s disease (Disorders) (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.1048.json	Parkinson’s disease (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.1049.json	Parkinsonism [Secondary] (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.1050.json	Parkinsonism [Secondary] (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.1065.json	Consciousness [Decreased Level] (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.1071.json	Drug Use [IV Evidence] (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.1072.json	Miosis (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.1076.json	Opioid Overdose and Poisoning (Tests for Opioids [Quantitative])	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.1083.json	Rash [Pustular Vesicular] (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.1084.json	Salivary Gland Swelling [Unspecified Cause] (Disorders) (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.1090.json	Syphilis [Congenital] (Disorders) (SNOMED)	active	2023-06	hl7